Month: December 2012
-
Drug offers new pain management therapy for diabetics
A study from the Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enrolled 60 patients with diabetic neuropathy in a 12-week placebo controlled clinical study.
-
Alzheimer’s researcher reveals a protein’s dual destructiveness – and therapeutic potential
A scientist at the University of British Columbia and Vancouver Coastal Health has identified the molecule that controls a scissor-like protein responsible for the production of plaques – the telltale sign of Alzheimer’s disease (AD).
-
Researchers find new genetic pathway behind neurodevelopmental disordersDes chercheurs découvrent de nouveaux chemins génétiques associés aux troubles neurodéveloppementaux
Researchers at the Douglas Mental Health University Institute, have discovered a new genetic process that could one day provide a novel target for the treatment of neurodevelopmental disorders, such as intellectual disability and autism.
-
Common diabetes drug promotes development of brain stem cells
SickKids researchers suggest metformin helps produce new brain cells and enhance memory TORONTO – Researchers at The Hospital for Sick Children (SickKids) have found that metformin, a drug commonly used to treat Type II diabetes, can help trigger the pathway used to instruct stem cells in the brain to become neural (nerve) cells.